Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Events

10 May 2016 - 16 May 2016
11 May 2016 - 13 May 2016

Evolutionary Changes Reproduced in the Lab by Manipulating Embryonic Development of Mice

By BiotechDaily International staff writers
Posted on 18 Aug 2014
Print article
Researchers have been able experimentally to reproduce in mice morphologic alterations that have taken millions of years to occur. Through small and gradual modifications in the embryonic development of mice teeth, produced in the laboratory, scientists have obtained teeth that morphologically are very similar to those observed in the fossil registry of rodent species that evolved from mice millions of years ago.

To modify the development of their teeth, the team from the Institute of Biotechnology of the University of Helsinki (Finland) worked with embryonic teeth cultures from mice not coded by the ectodysplasin A (EDA) protein, which regulates the formation of structures and differentiation of organs in the embryo throughout its development. The teeth obtained with these cultures which present this mutation develop into very fundamental forms, with very uniform crowns. Scientists gradually added different amounts of the EDA protein to the embryonic cells and let them develop.

The researchers observed that the teeth formed with different levels of complexity in their crown. The more primitive changes observed coincide with those which took place in animals of the Triassic period, some two hundred million years ago. The development of more posterior patterns corresponds with the different stages of evolution discovered in rodents that already became extinct in the Paleocene Epoch, approximately 60 million years ago. Researchers have therefore achieved the reproduction of the transitions observed in the fossil registry of mammal teeth.

The scientists were able to compare the shape of these teeth with a computer-generated prediction model created by Dr. Isaac Salazar-Ciudad, researcher at the Universitat Autònoma de Barcelona (UAB; Spain) and at the University of Helsinki, which reproduces how the tooth changes from a group of equal cells to a complicated three-dimensional (3D) structure, with the full shape of a molar tooth, computing the position of space of each cell. The model is capable of forecasting the changes in the morphology of the tooth when a gene is engineered, and therefore offers an explanation of the processes that cause these specific alterations to occur in the shape of teeth throughout evolution.

“Evolution has been explained as the ability of individuals to adapt to their environment in different ways,” Dr. Salazar-Ciudad stated, “But we do not know why or how individuals differ morphologically. The research helps to understand evolution, in each generation, as a game between the possible variations in form and natural selection.”

The research findings were published July 30, 2014, in the journal Nature.

Related Links:

Institute of Biotechnology of the University of Helsinki
Universitat Autònoma de Barcelona



Print article

Channels

Genomics/Proteomics

view channel

Cardiac Researchers Use Stem Cells to Generate Functional Heart Muscle

Stem cell researchers have developed a new technique to form micro-scale arrays of engineered heart muscle (EHM) from fewer than 10,000 starter cells without requirement for adherence features or extracellular matrix (ECM). Tissue engineering approaches have the potential to increase the physiologic relevance of cells,... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Business

view channel

European Biotech Agreement to Promote Antigen-Drug Conjugation Technology

Two European biotech companies have joined forces to exploit and commercialize an innovative, site-specific ADC (antigen-drug conjugate) conjugation technology. ProBioGen (Berlin, Germany), a company specializing in the development and manufacture of complex glycoproteins and Eucodis Bioscience (Vienna, Austria), a... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.